Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example

Colorectal cancer is a disease of the elderly. As older and frail patients are under-represented in clinical trials, most of the evidence available on treatment of older metastatic colorectal patients with cancer originates from pooled analyses of the older patients included in large prospective cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Winther, Stine Braendegaard, Jørgensen, Trine Lembrecht, Pfeiffer, Per, Qvortrup, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070237/
https://www.ncbi.nlm.nih.gov/pubmed/27843604
http://dx.doi.org/10.1136/esmoopen-2015-000021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070237/
https://www.ncbi.nlm.nih.gov/pubmed/27843604
http://dx.doi.org/10.1136/esmoopen-2015-000021

Ejemplares similares